Public research footprint of AP-HM, compiled from the ClinicalTrials.gov public registry.
Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Carcinoma, Non-Small-Cell Lung · Fascioscapulohumeral Muscular Dystrophy Type 1 · Developmental and Epileptic Encephalopathy
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.